InsiderTrades.com logo

ITRM Insider Trading

Insider Ownership Percentage: 2.00%
Insider Buying (Last 12 Months): $13,020.00
Insider Selling (Last 12 Months): $0.00

Iterum Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Iterum Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Iterum Therapeutics Share Price & Price History

Current Price: $0.03
Price Change: +0.30 (1.20%)
As of 04/9/2026 01:00 AM ET

This chart shows the closing price history over time for ITRM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Iterum Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2025Michael W DunneDirectorBuy6,000$0.37$2,220.00241,001View SEC Filing Icon  
8/8/2025Michael W DunneDirectorBuy15,000$0.72$10,800.00235,001View SEC Filing Icon  
12/22/2023Michael W DunneDirectorBuy25,000$1.40$35,000.00113,754View SEC Filing Icon  
11/22/2023Michael W DunneDirectorBuy20,000$2.03$40,600.0078,754View SEC Filing Icon  
11/20/2023Corey N FishmanCEOBuy10,000$1.59$15,900.0054,449View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Iterum Therapeutics (NASDAQ:ITRM)

9.21% of Iterum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ITRM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Iterum Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026Alchemi Wealth LLC268,886$90K0.0%N/A0.505%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC289,410$97K0.0%+1,893.5%0.543%Search for SEC Filing on Google Icon
1/22/2026Apollon Financial LLC630,250$0.21M0.0%+151.8%1.183%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC47,131$32K0.0%N/A0.098%Search for SEC Filing on Google Icon
11/10/2025OneDigital Investment Advisors LLC191,000$0.13M0.0%+18.6%0.398%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC92,943$92K0.0%N/A0.208%Search for SEC Filing on Google Icon
4/29/2025OneDigital Investment Advisors LLC101,000$0.12M0.0%N/A0.292%Search for SEC Filing on Google Icon
2/18/2025Alpine Global Management LLC15,000$27K0.0%-76.9%0.055%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP25,245$45K0.0%N/A0.092%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC21,207$38K0.0%N/A0.077%Search for SEC Filing on Google Icon
2/14/2025Alpine Global Management LLC15,000$27K0.0%-76.9%0.055%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC438,816$0.78M0.0%N/A1.595%Search for SEC Filing on Google Icon
1/31/2025Sanctuary Advisors LLC20,000$35K0.0%N/A0.073%Search for SEC Filing on Google Icon
1/30/2025Lee Financial Co16,000$28K0.0%N/A0.058%Search for SEC Filing on Google Icon
1/28/2025Apollon Financial LLC250,250$0.44M0.1%+11.3%0.909%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd33,040$36K0.0%N/A0.146%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC64,022$73K0.0%-42.0%0.387%Search for SEC Filing on Google Icon
8/4/2023Apollon Wealth Management LLC200,000$0.21M0.0%N/A1.542%Search for SEC Filing on Google Icon
11/10/2022New Leaf Venture Partners L.L.C.97,084$0.16M0.1%-93.3%0.794%Search for SEC Filing on Google Icon
10/6/2022Krilogy Financial LLC20,000$32K0.0%-90.0%0.163%Search for SEC Filing on Google Icon
7/14/2022Krilogy Financial LLC200,000$40K0.0%N/A0.109%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Iterum Therapeutics logo
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Read More on Iterum Therapeutics

Today's Range

Now: $0.03
Low: $0.03
High: $0.03

50 Day Range

MA: $0.18
Low: $0.03
High: $0.34

52 Week Range

Now: $0.03
Low: $0.03
High: $1.42

Volume

N/A

Average Volume

47,752,636 shs

Market Capitalization

$1.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.96

Who are the company insiders with the largest holdings of Iterum Therapeutics?

Iterum Therapeutics' top insider investors include:
  1. Corey N Fishman (CEO)
  2. Michael W Dunne (Director)
  3. Brenton Karl Ahrens (Director)
  4. Judith M Matthews (CFO)
  5. Sailaja Puttagunta (Insider)
  6. Alexander J Denner (Major Shareholder)
  7. David George Kelly (Director)
  8. Judith M Matthews (CFO)
  9. Mark Chin (Director)
  10. Michael W Dunne (Insider)
Learn More about top insider investors at Iterum Therapeutics.